COMMUNIQUÉS West-GlobeNewswire

-
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
28/03/2024 -
Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024
28/03/2024 -
SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
28/03/2024 -
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
28/03/2024 -
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split
28/03/2024 -
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
28/03/2024 -
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
28/03/2024 -
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
28/03/2024 -
Ardelyx, Inc. Reports Employment Inducement Grants
28/03/2024 -
ArriVent BioPharma Reports Full Year 2023 Financial Results
28/03/2024 -
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
28/03/2024 -
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
28/03/2024 -
CervoMed to Participate in Upcoming Investor Conferences
28/03/2024 -
Sharecare announces fourth quarter and full year 2023 financial results and operational highlights
28/03/2024 -
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
28/03/2024 -
Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium
28/03/2024 -
ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights
28/03/2024 -
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update
28/03/2024 -
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
28/03/2024
Pages